A
drug for treatment of cerebrovascular
disease is characterized by comprising 5-30 parts by weight of
Salvia miltiorrhiza, 10-15 parts by weight of
Ligusticum wallichii, 9-15 parts by weight of
Manis pentadactyla, 10-15 parts by weight of rhizoma polygonati, 9-15 parts by weight of white atractylodes
rhizome, 10-15 parts by weight of Chinese angelica, 15-30 parts by weight of
Astragalus membranaceus, 3-9 parts by weight of pseudo-
ginseng, 6-9 parts by weight of rhizoma cimicifugae, 2.5-5 parts by weight of leech, 6-10 parts by weight of
earthworm, 10-15 parts by weight of ox horn, 3-6 parts by weight of
scorpion and 4.5-10 parts by weight of stiff silkworm. The
drug has the effects of activating
blood circulation to dissipate stasis, clearing and activating the channels and collaterals, expanding blood vessels of brain, and improving
blood circulation and blood
rheology, and can be used for strokes caused by
sputum stasis and collateral obstruction, symptoms are as follows: numbness of limbs, dizziness,
speech disorder, skewed mouth and tongue, sluggish look, hemiplegia and sudden faint, also can treat ischemic
cerebral embolism, cerebral vascular atherosclerosis and
sequela of cerebral hemorrhage, can restore cerebral blood flows, promotes the
rehabilitation of
paralysis, and improves quality of living and life.